Buy Glenmark Pharma, says Sudarshan Sukhani

One can buy Glenmark Pharma, says Sudarshan Sukhani of s2analytics.com.

Sukhani told CNBC-TV18, "Glenmark Pharma is bottoming out. It is a part of pharmaceutical sector, which itself is good enough. A small correction in Glenmark is over. We had a big move yesterday and two days ago we had a similar move then the prices declined."
He further added, "The fact that prices can be pushed at higher levels from the opening price suggests that something good is going on. I would be a buyer. Expect a target of Rs 520 or close for the very short-term trader and then see how it goes."
At 10:21 hrs Glenmark Pharma was quoting at Rs 507.80, up Rs 15.55, or 3.16 percent. It has touched an intraday high of Rs 519 and an intraday low of Rs 495.